Global In Vitro Assays to Diagnose Infectious Diseases Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for In Vitro Assays to Diagnose Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Assays to Diagnose Infectious Diseases.
The In Vitro Assays to Diagnose Infectious Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In Vitro Assays to Diagnose Infectious Diseases market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Assays to Diagnose Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Assays to Diagnose Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The In Vitro Assays to Diagnose Infectious Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In Vitro Assays to Diagnose Infectious Diseases market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Assays to Diagnose Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- QIAGEN
- BD
- bioMerieux SA
- F. Hoffmann-La Roche, Ltd.
- Hologic, Inc. (Gen-Probe)
- Abbott
- Quidel Corp.?
- iemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Danaher Corp.
- OraSure Technologies, Inc
- Immunoassay
- Molecular Diagnosis
- Others
- Streptococcus
- Clostridium Difficile
- Candida
- Tuberculosis
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Assays to Diagnose Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Immunoassay
1.2.3 Molecular Diagnosis
1.2.4 Others
1.3 Market by Application
1.3.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Streptococcus
1.3.3 Clostridium Difficile
1.3.4 Candida
1.3.5 Tuberculosis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Perspective (2018-2029)
2.2 In Vitro Assays to Diagnose Infectious Diseases Growth Trends by Region
2.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Region (2018-2023)
2.2.3 In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2024-2029)
2.3 In Vitro Assays to Diagnose Infectious Diseases Market Dynamics
2.3.1 In Vitro Assays to Diagnose Infectious Diseases Industry Trends
2.3.2 In Vitro Assays to Diagnose Infectious Diseases Market Drivers
2.3.3 In Vitro Assays to Diagnose Infectious Diseases Market Challenges
2.3.4 In Vitro Assays to Diagnose Infectious Diseases Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue
3.1.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue (2018-2023)
3.1.2 Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Players (2018-2023)
3.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Assays to Diagnose Infectious Diseases Revenue
3.4 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio
3.4.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2022
3.5 In Vitro Assays to Diagnose Infectious Diseases Key Players Head office and Area Served
3.6 Key Players In Vitro Assays to Diagnose Infectious Diseases Product Solution and Service
3.7 Date of Enter into In Vitro Assays to Diagnose Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES BREAKDOWN DATA BY TYPE
4.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Type (2018-2023)
4.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2024-2029)
5 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES BREAKDOWN DATA BY APPLICATION
5.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Application (2018-2023)
5.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
6.2 North America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
6.4 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
7.2 Europe In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
7.4 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
8.2 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2023)
8.4 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
9.2 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
9.4 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
10.2 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
10.4 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 QIAGEN
11.1.1 QIAGEN Company Detail
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Introduction
11.1.4 QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.1.5 QIAGEN Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Introduction
11.2.4 BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.2.5 BD Recent Development
11.3 bioMerieux SA
11.3.1 bioMerieux SA Company Detail
11.3.2 bioMerieux SA Business Overview
11.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Introduction
11.3.4 bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.3.5 bioMerieux SA Recent Development
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Detail
11.4.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.4.4 F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.4.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Detail
11.5.2 Hologic, Inc. (Gen-Probe) Business Overview
11.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Introduction
11.5.4 Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.5.5 Hologic, Inc. (Gen-Probe) Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Introduction
11.6.4 Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Quidel Corp.?
11.7.1 Quidel Corp.? Company Detail
11.7.2 Quidel Corp.? Business Overview
11.7.3 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Introduction
11.7.4 Quidel Corp.? Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.7.5 Quidel Corp.? Recent Development
11.8 iemens Healthineers AG
11.8.1 iemens Healthineers AG Company Detail
11.8.2 iemens Healthineers AG Business Overview
11.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Introduction
11.8.4 iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.8.5 iemens Healthineers AG Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Detail
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Detail
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.10.4 Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.10.5 Danaher Corp. Recent Development
11.11 OraSure Technologies, Inc
11.11.1 OraSure Technologies, Inc Company Detail
11.11.2 OraSure Technologies, Inc Business Overview
11.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Introduction
11.11.4 OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.11.5 OraSure Technologies, Inc Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Immunoassay
1.2.3 Molecular Diagnosis
1.2.4 Others
1.3 Market by Application
1.3.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Streptococcus
1.3.3 Clostridium Difficile
1.3.4 Candida
1.3.5 Tuberculosis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Perspective (2018-2029)
2.2 In Vitro Assays to Diagnose Infectious Diseases Growth Trends by Region
2.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Region (2018-2023)
2.2.3 In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2024-2029)
2.3 In Vitro Assays to Diagnose Infectious Diseases Market Dynamics
2.3.1 In Vitro Assays to Diagnose Infectious Diseases Industry Trends
2.3.2 In Vitro Assays to Diagnose Infectious Diseases Market Drivers
2.3.3 In Vitro Assays to Diagnose Infectious Diseases Market Challenges
2.3.4 In Vitro Assays to Diagnose Infectious Diseases Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue
3.1.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue (2018-2023)
3.1.2 Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Players (2018-2023)
3.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Assays to Diagnose Infectious Diseases Revenue
3.4 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio
3.4.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2022
3.5 In Vitro Assays to Diagnose Infectious Diseases Key Players Head office and Area Served
3.6 Key Players In Vitro Assays to Diagnose Infectious Diseases Product Solution and Service
3.7 Date of Enter into In Vitro Assays to Diagnose Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES BREAKDOWN DATA BY TYPE
4.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Type (2018-2023)
4.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2024-2029)
5 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES BREAKDOWN DATA BY APPLICATION
5.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Application (2018-2023)
5.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
6.2 North America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
6.4 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
7.2 Europe In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
7.4 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
8.2 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2023)
8.4 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
9.2 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
9.4 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
10.2 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023)
10.4 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 QIAGEN
11.1.1 QIAGEN Company Detail
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Introduction
11.1.4 QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.1.5 QIAGEN Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Introduction
11.2.4 BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.2.5 BD Recent Development
11.3 bioMerieux SA
11.3.1 bioMerieux SA Company Detail
11.3.2 bioMerieux SA Business Overview
11.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Introduction
11.3.4 bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.3.5 bioMerieux SA Recent Development
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Detail
11.4.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.4.4 F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.4.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Detail
11.5.2 Hologic, Inc. (Gen-Probe) Business Overview
11.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Introduction
11.5.4 Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.5.5 Hologic, Inc. (Gen-Probe) Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Introduction
11.6.4 Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Quidel Corp.?
11.7.1 Quidel Corp.? Company Detail
11.7.2 Quidel Corp.? Business Overview
11.7.3 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Introduction
11.7.4 Quidel Corp.? Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.7.5 Quidel Corp.? Recent Development
11.8 iemens Healthineers AG
11.8.1 iemens Healthineers AG Company Detail
11.8.2 iemens Healthineers AG Business Overview
11.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Introduction
11.8.4 iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.8.5 iemens Healthineers AG Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Detail
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Detail
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.10.4 Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.10.5 Danaher Corp. Recent Development
11.11 OraSure Technologies, Inc
11.11.1 OraSure Technologies, Inc Company Detail
11.11.2 OraSure Technologies, Inc Business Overview
11.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Introduction
11.11.4 OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
11.11.5 OraSure Technologies, Inc Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Immunoassay
Table 3. Key Players of Molecular Diagnosis
Table 4. Key Players of Others
Table 5. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2018-2023)
Table 9. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2024-2029)
Table 11. In Vitro Assays to Diagnose Infectious Diseases Market Trends
Table 12. In Vitro Assays to Diagnose Infectious Diseases Market Drivers
Table 13. In Vitro Assays to Diagnose Infectious Diseases Market Challenges
Table 14. In Vitro Assays to Diagnose Infectious Diseases Market Restraints
Table 15. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players (2018-2023)
Table 17. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2022)
Table 18. Ranking of Global Top In Vitro Assays to Diagnose Infectious Diseases Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players In Vitro Assays to Diagnose Infectious Diseases Product Solution and Service
Table 22. Date of Enter into In Vitro Assays to Diagnose Infectious Diseases Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2018-2023)
Table 26. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2024-2029)
Table 28. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2018-2023)
Table 30. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2024-2029)
Table 32. North America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 47. QIAGEN Company Detail
Table 48. QIAGEN Business Overview
Table 49. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product
Table 50. QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 51. QIAGEN Recent Development
Table 52. BD Company Detail
Table 53. BD Business Overview
Table 54. BD In Vitro Assays to Diagnose Infectious Diseases Product
Table 55. BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 56. BD Recent Development
Table 57. bioMerieux SA Company Detail
Table 58. bioMerieux SA Business Overview
Table 59. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product
Table 60. bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 61. bioMerieux SA Recent Development
Table 62. F. Hoffmann-La Roche, Ltd. Company Detail
Table 63. F. Hoffmann-La Roche, Ltd. Business Overview
Table 64. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product
Table 65. F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 66. F. Hoffmann-La Roche, Ltd. Recent Development
Table 67. Hologic, Inc. (Gen-Probe) Company Detail
Table 68. Hologic, Inc. (Gen-Probe) Business Overview
Table 69. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product
Table 70. Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 71. Hologic, Inc. (Gen-Probe) Recent Development
Table 72. Abbott Company Detail
Table 73. Abbott Business Overview
Table 74. Abbott In Vitro Assays to Diagnose Infectious Diseases Product
Table 75. Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Quidel Corp.? Company Detail
Table 78. Quidel Corp.? Business Overview
Table 79. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product
Table 80. Quidel Corp.? Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 81. Quidel Corp.? Recent Development
Table 82. iemens Healthineers AG Company Detail
Table 83. iemens Healthineers AG Business Overview
Table 84. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product
Table 85. iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 86. iemens Healthineers AG Recent Development
Table 87. Bio-Rad Laboratories, Inc. Company Detail
Table 88. Bio-Rad Laboratories, Inc. Business Overview
Table 89. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product
Table 90. Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 91. Bio-Rad Laboratories, Inc. Recent Development
Table 92. Danaher Corp. Company Detail
Table 93. Danaher Corp. Business Overview
Table 94. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product
Table 95. Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 96. Danaher Corp. Recent Development
Table 97. OraSure Technologies, Inc Company Detail
Table 98. OraSure Technologies, Inc Business Overview
Table 99. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product
Table 100. OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 101. OraSure Technologies, Inc Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 1. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Immunoassay
Table 3. Key Players of Molecular Diagnosis
Table 4. Key Players of Others
Table 5. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2018-2023)
Table 9. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2024-2029)
Table 11. In Vitro Assays to Diagnose Infectious Diseases Market Trends
Table 12. In Vitro Assays to Diagnose Infectious Diseases Market Drivers
Table 13. In Vitro Assays to Diagnose Infectious Diseases Market Challenges
Table 14. In Vitro Assays to Diagnose Infectious Diseases Market Restraints
Table 15. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players (2018-2023)
Table 17. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2022)
Table 18. Ranking of Global Top In Vitro Assays to Diagnose Infectious Diseases Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players In Vitro Assays to Diagnose Infectious Diseases Product Solution and Service
Table 22. Date of Enter into In Vitro Assays to Diagnose Infectious Diseases Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2018-2023)
Table 26. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2024-2029)
Table 28. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2018-2023)
Table 30. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2024-2029)
Table 32. North America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 47. QIAGEN Company Detail
Table 48. QIAGEN Business Overview
Table 49. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product
Table 50. QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 51. QIAGEN Recent Development
Table 52. BD Company Detail
Table 53. BD Business Overview
Table 54. BD In Vitro Assays to Diagnose Infectious Diseases Product
Table 55. BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 56. BD Recent Development
Table 57. bioMerieux SA Company Detail
Table 58. bioMerieux SA Business Overview
Table 59. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product
Table 60. bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 61. bioMerieux SA Recent Development
Table 62. F. Hoffmann-La Roche, Ltd. Company Detail
Table 63. F. Hoffmann-La Roche, Ltd. Business Overview
Table 64. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product
Table 65. F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 66. F. Hoffmann-La Roche, Ltd. Recent Development
Table 67. Hologic, Inc. (Gen-Probe) Company Detail
Table 68. Hologic, Inc. (Gen-Probe) Business Overview
Table 69. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product
Table 70. Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 71. Hologic, Inc. (Gen-Probe) Recent Development
Table 72. Abbott Company Detail
Table 73. Abbott Business Overview
Table 74. Abbott In Vitro Assays to Diagnose Infectious Diseases Product
Table 75. Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Quidel Corp.? Company Detail
Table 78. Quidel Corp.? Business Overview
Table 79. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product
Table 80. Quidel Corp.? Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 81. Quidel Corp.? Recent Development
Table 82. iemens Healthineers AG Company Detail
Table 83. iemens Healthineers AG Business Overview
Table 84. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product
Table 85. iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 86. iemens Healthineers AG Recent Development
Table 87. Bio-Rad Laboratories, Inc. Company Detail
Table 88. Bio-Rad Laboratories, Inc. Business Overview
Table 89. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product
Table 90. Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 91. Bio-Rad Laboratories, Inc. Recent Development
Table 92. Danaher Corp. Company Detail
Table 93. Danaher Corp. Business Overview
Table 94. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product
Table 95. Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 96. Danaher Corp. Recent Development
Table 97. OraSure Technologies, Inc Company Detail
Table 98. OraSure Technologies, Inc Business Overview
Table 99. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product
Table 100. OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023) & (US$ Million)
Table 101. OraSure Technologies, Inc Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Type: 2022 VS 2029
Figure 3. Immunoassay Features
Figure 4. Molecular Diagnosis Features
Figure 5. Others Features
Figure 6. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Application: 2022 VS 2029
Figure 8. Streptococcus Case Studies
Figure 9. Clostridium Difficile Case Studies
Figure 10. Candida Case Studies
Figure 11. Tuberculosis Case Studies
Figure 12. Others Case Studies
Figure 13. In Vitro Assays to Diagnose Infectious Diseases Report Years Considered
Figure 14. Global In Vitro Assays to Diagnose Infectious Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global In Vitro Assays to Diagnose Infectious Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region: 2022 VS 2029
Figure 17. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players in 2022
Figure 18. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2022
Figure 20. North America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 22. United States In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 26. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2018-2029)
Figure 34. China In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 42. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 46. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. QIAGEN Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 49. BD Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 50. bioMerieux SA Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 51. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 52. Hologic, Inc. (Gen-Probe) Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 54. Quidel Corp.? Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 55. iemens Healthineers AG Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 56. Bio-Rad Laboratories, Inc. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 57. Danaher Corp. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 58. OraSure Technologies, Inc Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Figure 1. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Type: 2022 VS 2029
Figure 3. Immunoassay Features
Figure 4. Molecular Diagnosis Features
Figure 5. Others Features
Figure 6. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Application: 2022 VS 2029
Figure 8. Streptococcus Case Studies
Figure 9. Clostridium Difficile Case Studies
Figure 10. Candida Case Studies
Figure 11. Tuberculosis Case Studies
Figure 12. Others Case Studies
Figure 13. In Vitro Assays to Diagnose Infectious Diseases Report Years Considered
Figure 14. Global In Vitro Assays to Diagnose Infectious Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global In Vitro Assays to Diagnose Infectious Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region: 2022 VS 2029
Figure 17. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players in 2022
Figure 18. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2022
Figure 20. North America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 22. United States In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 26. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2018-2029)
Figure 34. China In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 42. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2018-2029)
Figure 46. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. QIAGEN Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 49. BD Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 50. bioMerieux SA Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 51. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 52. Hologic, Inc. (Gen-Probe) Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 54. Quidel Corp.? Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 55. iemens Healthineers AG Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 56. Bio-Rad Laboratories, Inc. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 57. Danaher Corp. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 58. OraSure Technologies, Inc Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
